Vienna
Congress Preview
Our review and coverage of EULAR 2024 highlights the most relevant data on RA, PsA, and axSpA and developing therapeutic options, with our brochures highlighting key posters and oral presentations ahead of the congress.
Coverage of key data relating to the science of inflammatory diseases and new developing therapeutic options that target immune-mediated signalling pathways presented at key congresses and reviewed for your information.
June 12th–15th
Our review and coverage of EULAR 2024 highlights the most relevant data on RA, PsA, and axSpA and developing therapeutic options, with our brochures highlighting key posters and oral presentations ahead of the congress.